Akcea, A Wholly Owned Subsidiary Of Ionis Pharmaceutical, Set To IPO
June 27, 2017 at 17:30 PM EDT
Akcea Therapeutics, a wholly-owned subsidiary of Ionis Pharmaceutical, is expected to IPO on Friday, June 30.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.